How Single-Use Technologies Are Transforming Biopharmaceutical Manufacturing

Overview

M2Square Consultancy estimates that the global Single-Use Bioprocessing Market was valued at USD 34.0 billion in 2025 and is projected to reach USD 110.1 billion by 2033, expanding at a CAGR of 16.3% during the forecast period.

Single-use bioprocessing uses disposable equipment and components in biopharmaceutical manufacturing instead of relying entirely on traditional reusable stainless-steel systems. Common products include single-use bioreactors, mixing systems, tubing, bags, connectors, filters, and sampling assemblies.

These technologies are increasingly used in the production of monoclonal antibodies, vaccines, recombinant proteins, cell and gene therapies, and other biologics. Their adoption is supported by the need for flexible production capacity, reduced cleaning requirements, and faster changeovers between manufacturing batches.

As biopharmaceutical pipelines expand and production needs become more diverse, single-use systems are becoming an important part of modern manufacturing strategies.

Market Snapshot

• Market size (2025): USD 34.0 billion

• Projected market size (2033): USD 110.1 billion

• CAGR: 16.3%

• Key products: Single-use bioreactors, bags, tubing, filters, connectors, and mixing systems

• Major applications: Monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins

• Key growth drivers: Biologics demand, manufacturing flexibility, and reduced cleaning and changeover requirements

Request a Sample PDF:https://m2squareconsultancy.com/request-sample/single-use-bioprocessing-market/311

Key Growth Drivers

1. Rising Demand for Biopharmaceuticals

The growing use of biologics and advanced therapies is increasing demand for adaptable manufacturing infrastructure. Single-use equipment can help facilities accommodate different production processes and changing batch requirements.

2. Reduced Cleaning and Changeover Requirements

Traditional reusable equipment often requires cleaning and, where applicable, sterilization between production runs. Single-use systems can reduce these activities for the components they replace, potentially shortening changeovers and simplifying certain manufacturing workflows.

3. Growth in Cell and Gene Therapies

Cell and gene therapy manufacturing can involve specialized processes and smaller production volumes. Single-use bags, tubing, connectors, and processing assemblies can support flexible workflows, although system selection depends on the therapy and manufacturing process.

4. Expansion of Contract Manufacturing

Contract development and manufacturing organizations (CDMOs) serve multiple biopharmaceutical customers with varying production requirements. Single-use technologies can help these organizations adapt facilities to different products and manufacturing schedules.

Explore the full report:https://m2squareconsultancy.com/reports/single-use-bioprocessing-market

Major Market Trends

Increasing Adoption of Single-Use Bioreactors

Single-use bioreactors are gaining attention because they can support flexible production setups without requiring a dedicated stainless-steel vessel for every process. Their suitability depends on scale, product characteristics, process control requirements, and manufacturing objectives.

Integration of Automation and Process Monitoring

Manufacturers are combining disposable equipment with sensors, automated controls, and digital monitoring tools. These technologies can help improve process visibility, support consistency, and enable better monitoring of critical manufacturing parameters.

Growing Demand for High-Quality Disposable Components

Bags, tubing, filters, connectors, and other fluid-contact components must meet demanding quality requirements. Manufacturers are focusing on material compatibility, extractables and leachables assessment, supply reliability, and product consistency.

Focus on Sustainability and Waste Management

Single-use systems can reduce some water, cleaning chemical, and energy requirements associated with reusable equipment. However, they also generate disposable plastic waste. Manufacturers are evaluating life-cycle impacts, recycling options, material reduction, and responsible waste management.

Key Challenges

Plastic Waste and Environmental Concerns

The disposal of single-use components creates environmental challenges, particularly where recycling infrastructure is limited. Companies must evaluate waste handling and sustainability alongside manufacturing benefits.

Supply Chain Dependence

Bioprocessing operations depend on consistent access to specialized bags, filters, tubing, connectors, and other components. Supply interruptions can affect production schedules, making supplier qualification and contingency planning important.

Material Compatibility and Product Quality

Disposable components must be compatible with the process and the product being manufactured. Extractables, leachables, material integrity, and potential product interactions require appropriate evaluation.

Scale-Up Limitations

Not every manufacturing process can transition to single-use systems without technical or economic trade-offs. Large-volume production, process-specific requirements, and facility design can influence the choice between disposable, reusable, or hybrid systems.

Regional Outlook

North America: Demand is supported by an established biopharmaceutical industry, biologics development, and a strong presence of biotechnology companies and contract manufacturers.

Europe: Biopharmaceutical manufacturing, investment in advanced therapies, and established pharmaceutical infrastructure support adoption of flexible processing technologies.

Asia-Pacific: Expanding biologics manufacturing, investment in biotechnology, and growing contract manufacturing capacity are creating opportunities for single-use equipment suppliers.

Latin America and the Middle East & Africa: Adoption opportunities may increase as regional biopharmaceutical manufacturing capabilities and healthcare investment develop. Growth will vary by country and facility readiness.

Competitive Landscape

Competition in the Single-Use Bioprocessing Market is influenced by product quality, portfolio breadth, process compatibility, regulatory support, supply reliability, and technical service. Suppliers offer a range of disposable components and integrated systems for biopharmaceutical production.

Companies active in the broader single-use bioprocessing ecosystem include Sartorius, Thermo Fisher Scientific, Merck KGaA, Danaher, Cytiva, and Avantor. Their portfolios differ, and their inclusion does not imply that every company supplies every product category.

Future Outlook

The Single-Use Bioprocessing Market is projected to increase from USD 34.0 billion in 2025 to USD 110.1 billion by 2033, at a CAGR of 16.3%. Growth is expected to be influenced by biologics production, cell and gene therapy development, flexible manufacturing requirements, and investment in bioprocessing infrastructure.

As adoption expands, manufacturers will continue to balance operational flexibility and process efficiency with supply security, material compatibility, and environmental considerations. Suppliers that provide reliable components, technical support, and consistent quality may be well positioned to address evolving customer needs.

Frequently Asked Questions

1. What is the Single-Use Bioprocessing Market?

It covers disposable equipment and components used in biopharmaceutical manufacturing, including bioreactor systems, bags, tubing, filters, connectors, and mixing assemblies.

2. What is the projected market size by 2033?

The global market is projected to reach USD 110.1 billion by 2033, based on the supplied estimates.

3. What is the expected CAGR?

The market is projected to grow at a CAGR of 16.3% during the forecast period provided.

4. What are the major applications of single-use bioprocessing?

Applications include the production of monoclonal antibodies, vaccines, recombinant proteins, and certain cell and gene therapies.

5. What are the benefits of single-use bioprocessing systems?

Potential benefits include reduced cleaning requirements for replaced components, faster changeovers, flexible facility design, and adaptability to different production needs.

6. What challenges affect market growth?

Key challenges include disposable plastic waste, supply chain risks, material compatibility, component quality, and technical limitations in some large-scale applications.

Conclusion

The Single-Use Bioprocessing Market is becoming increasingly important to biopharmaceutical manufacturing. Demand for biologics, advanced therapies, and flexible production systems is supporting adoption across the industry. At the same time, manufacturers must address supply reliability, material compatibility, and sustainability to achieve long-term operational benefits.

Explore the Single-Use Bioprocessing Market to understand its size, emerging trends, growth opportunities, regional outlook, and competitive landscape. Contact M2Square Consultancy to request a sample PDF and access insights relevant to your business and strategic planning.

About M2Square Consultancy

M2Square Consultancy provides market research and business intelligence to help organizations understand industry trends, evaluate competitive landscapes, and identify strategic growth opportunities.

Author: Shubham | Senior Healthcare & Biotechnology Market Research Analyst | M2Square Consultancy

Related Reports:

https://m2squareconsultancy.com/reports/healthcare-in-metaverse-market

https://m2squareconsultancy.com/reports/hemodialysis-equipment-market

https://m2squareconsultancy.com/reports/medical-lasers-market

https://m2squareconsultancy.com/reports/bone-and-joint-health-supplements-market

https://m2squareconsultancy.com/reports/global-ventilators-market